Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The UK's NHS has begun evaluating GLP-1 obesity coverage, with NICE's appraisal of semaglutide for obesity resulting in conditional approval for use through specialist weight management services a restrictive but meaningful coverage expansion that will grow over time as service capacity expands
"I think the introduction of weight loss jabs is going to perpetuate those norms and expectations around having the lowest possible body weight." Williams emphasises that the drugs are not appropriate for people who do not fit the prescribed category
If you take other prescription drugs or over-the-counter medicine with semaglutide, this can also change how it works and may cause side effects
GLP-1 weight loss drugs are reshaping modern dating and intimacy
